BioXcel Therapeutics, Inc. Quarterly Nonoperating Income (Expense) in USD for Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
BioXcel Therapeutics, Inc. quarterly Nonoperating Income (Expense) history and growth rate for Q3 2022.
  • BioXcel Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2022 was $62K.
Nonoperating Income (Expense), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $62K Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.